424B4424B4
May 8, 2026Final prospectus0001193125-26-214819
All companies
Trade Odyssey Therapeutics IncOdyssey Therapeutics Announces Pricing of Upsized Initial Public Offering Odyssey Therapeutics Announces $279 Million Upsized IPO, Concurrent $25 Million Private Placement Covington Represents Odyssey Therapeutics on Upsized $304 Million Initial Public Offering Odyssey Therapeutics Files for Proposed Nasdaq IPO
Odyssey Therapeutics Inc
ODTXPublic
PublicUnited States(NASDAQ Capital)Best valuation $899.15MSince IPO +4.00%1 market
Public listing
Listed· NASDAQ Capital· Listing market: United StatesListing date
May 8, 2026
Final IPO price
$18.00
Shares offered
15,500,000
Offering proceeds
$279M
Sources: sec-harvest, nasdaq
IPO Calendar · NASDAQIPO
ODTXPrice
$18.72
24h
-1.84%
Valuation
$899.15M
24h volume
$7.04M
Type
IPO
Trade Odyssey Therapeutics IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
About Odyssey Therapeutics Inc
Odyssey Therapeutics Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Odyssey Therapeutics Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
Final prospectusEDGAR filings resolved from ODTX / CIK 0001882782.
May 7, 2026Effective9999999995-26-001538
May 7, 2026Exchange registration0001354457-26-000416
8-A12B8-A12B
May 5, 2026Exchange registration0001193125-26-205798
S-1/AS-1/A
May 4, 2026Amended0001193125-26-202398
S-1S-1
Apr 17, 2026Filed0001193125-26-161514
DRS/Afilename1.htm
Apr 3, 2026Confidential draft0001193125-26-142305
DRS/Afilename1.htm
Mar 16, 2026Confidential draft0001193125-26-108608
Feb 6, 2026Confidential draft0001193125-26-041396
RWRW
Jun 9, 2025Withdrawn0001193125-25-137861
S-1S-1
Jan 17, 2025Filed0001193125-25-008362
DRS/Afilename1.htm
Dec 5, 2024Confidential draft0000950123-24-012178
Latest Odyssey Therapeutics Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
Odyssey Therapeutics (Investor Relations)May 7, 2026IPO filing
Company press release on IPO pricing (upsized deal) for Odyssey Therapeutics (ODTX).
CooleyMay 7, 2026IPO context
IPO announcement coverage tied directly to Odyssey Therapeutics’ upsized IPO and concurrent private placement.
Covington & Burling LLPMay 7, 2026IPO context
Legal/transaction coverage confirming upsized IPO details and that shares began trading on Nasdaq Capital Market under ODTX.
TrustFinance BlogIPO context
Covers the company’s IPO filing for Nasdaq (proposed IPO) for Odyssey Therapeutics.
Odyssey Therapeutics Inc IPO — frequently asked questions
- When did Odyssey Therapeutics Inc go public?
- Odyssey Therapeutics Inc completed its IPO on May 8, 2026 on NASDAQ Capital under the ticker ODTX and now trades publicly.
- What was Odyssey Therapeutics Inc's IPO price?
- Odyssey Therapeutics Inc priced its IPO at $18.00 per share.
- Can I buy Odyssey Therapeutics Inc stock?
- Yes — Odyssey Therapeutics Inc is publicly traded on NASDAQ Capital as ODTX. You can follow its live price, valuation and post-IPO performance above.
- What is Odyssey Therapeutics Inc's valuation?
- Odyssey Therapeutics Inc's most recent valuation tracked here is $899.15M, derived from live market prices.